Clinical Trial Update: Safety and Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the safety and feasibility of sodium oxybate in patients with mild Alzheimer's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Xyrem (Sodium Oxybate)

Snippet

Sponsor: Clayton Sleep Insititute | Conditions: Mild Alzheimer's Disease | Phase 4 | Status: TERMINATED